Page last updated: 2024-09-03

u 86983 and milrinone

u 86983 has been researched along with milrinone in 1 studies

Compound Research Comparison

Studies
(u 86983)
Trials
(u 86983)
Recent Studies (post-2010)
(u 86983)
Studies
(milrinone)
Trials
(milrinone)
Recent Studies (post-2010) (milrinone)
6001,605235452

Protein Interaction Comparison

ProteinTaxonomyu 86983 (IC50)milrinone (IC50)
Phosphodiesterase Bos taurus (cattle)1
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.3
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8AHomo sapiens (human)0.3
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.52
Prostaglandin G/H synthase 1Homo sapiens (human)4.7
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)6
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)6
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)6
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)3.15
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)1.8674
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)1.8177
cGMP-specific 3',5'-cyclic phosphodiesteraseBos taurus (cattle)5
Phosphodiesterase Sus scrofa (pig)0.843

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbott, BM; Thompson, PE1

Other Studies

1 other study(ies) available for u 86983 and milrinone

ArticleYear
PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues.
    Bioorganic & medicinal chemistry letters, 2004, Jun-07, Volume: 14, Issue:11

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Chromones; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Humans; Morpholines; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship

2004